Administrative Core

该范德比尔特CDTR是一个独特的组织，跨学科的计划，涉及38积极资助的教师 分布在大学的三所学校和四个学院。五名额外资助的教师 其主要任命是在梅哈里医学院也参加。在Elasy博士的领导下， 核心将负责中心资源的分配和监督， 整合CDTR的组成部分和活动。特别是行政核心积极协调 并监督试点和可行性活动以及浓缩活动。已创建网站 （https：//labnodes.vanderbilt.edu/cdtr），并仔细维护。 随着区域核心领导层的变化，中心的领导层总体保持连续性， 行为干预技术和服务（奥斯本）和一个新的领导者的浓缩核心 （威尔金斯）。范德比尔特CDTR继续在汤姆A。Elasy，医学博士，谁是PI/主任 中心Elasy博士是Ann和Roscoe R。糖尿病中心的罗宾逊主席，范德比尔特的主任 普通内科和公共卫生部，范德比尔特埃斯金德糖尿病中心前主任 诊所，并在过去5年中指导了目前的CDTR。他由一名副主任协助 （Russell Rothman，医学博士）和科学执行委员会（大卫Schulndt，博士，Shari Barkin，医学博士， 钱德拉奥斯本，博士，Robert Greevey博士，Consuelo Wilkins，医学博士，玛格丽特·哈格里夫斯博士）。一个 内部咨询小组由Al Powers，M.D.（范德比尔特糖尿病研究与培训中心主任 Gordon Bernard，M.D.（主任，范德比尔特CTSA）和罗伯特Dittus，医学博士，（导演，范德比尔特 医学和公共卫生研究所）。所有三名内部顾问成员都在 范德比尔特提高中心的知名度和有效性。这组调查人员带来了 相当多的科学经验，行政和管理技能，以及范德比尔特CDTR的连续性。 一个外部咨询委员会访问了范德比尔特，与浓缩活动（伊丽莎白 步行者，博士来自爱因斯坦，威廉赫尔曼，医学博士。来自密歇根大学，还有托马斯·凯瑟林， M.D.来自北卡罗来纳州大学），并带来了差距研究领域的国家专业知识， 社区参与研究、信息技术和实施科学。Elasy博士将提供 每年向外部和内部咨询委员会提供最新情况，以反映中心目标的进展情况。的 主任、副主任和科学执行委员会将每月举行会议，审查核心利用情况， 讨论丰富活动，审查初级教师（资助和尚未资助）的进展，并考虑 除了预定的研讨会，期刊俱乐部和当地工作之外，还有更多的合作机会， 中求进工作总

The Vanderbilt CDTR is a distinct organizational, interdisciplinary program involving 38 actively funded faculty distributed among three schools and four colleges of the University. Five additional funded faculty members whose primary appointment is at Meharry Medical School also participate. Under the leadership of Dr. Elasy, the core will be responsible for the allocation and oversight of Center resources and the coordination and integration of the CDTR components and activities. In particular, the administrative core actively coordinates and oversees Pilot and Feasibility activities as well as Enrichment activities. A web site has been created (https://labnodes.vanderbilt.edu/cdtr) and is carefully maintained. There is general continuity in the leadership of the Center with a change in the leadership of a regional core for Behavioral Intervention Technologies and Services (Osborn) and a new leader for the enrichment core (Wilkins). The Vanderbilt CDTR continues under the direction of Tom A. Elasy, M.D., who is PI/Director of the Center. Dr. Elasy is the Ann and Roscoe R. Robinson Chair in the Diabetes Center, Director of the Vanderbilt Division of General Internal Medicine and Public Health, former director of the Vanderbilt Eskind Diabetes Clinic, and has directed the current CDTR for the past 5 years. He is assisted by an Associate Director (Russell Rothman, M.D.) and a Scientific Executive Committee (David Schulndt, Ph.D., Shari Barkin, M.D., Chandra Osborn, Ph.D., Robert Greevey, Ph.D., Consuelo Wilkins, M.D., Margaret Hargraeves, Ph.D.). An internal advisory group consists of Al Powers, M.D. (Director, Vanderbilt Diabetes Research and Training Center), Gordon Bernard, M.D. (Director, Vanderbilt CTSA) and Robert Dittus, M.D., (Director, Vanderbilt Institute for Medicine and Public Health). All three internal advisory members hold senior positions within Vanderbilt enhancing the visibility and effectiveness of the center. This group of investigators brings considerable scientific experience, administrative and managerial skills, and continuity to the Vanderbilt CDTR. An external advisory committee has visited Vanderbilt in conjunction with enrichment activities (Elizabeth Walker, Ph.D. from Einstein, William Herman, M.D. from the University of Michigan, and Thomas Keyserling, M.D. from the University of North Carolina ) and bring national expertise in the areas of disparity research, community engaged research, information technology and implementation science. Dr. Elasy will provide an annual update to the external and internal advisory committee to reflect progress on center goals. The Director, Associate Director and Scientific Executive Committee will meet monthly to review core utilization, discuss enrichment activities, review progress of junior faculty (funded and not yet funded) and consider additional opportunities for collaboration beyond scheduled seminars, journal clubs, and local works-in- progress.